Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with genetically defined diseases.
Stock is 

SEC Filing Details

Document Details

Form
Filing Date
Apr 21, 2021
Document Date
Apr 19, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Agios Pharmaceuticals, Inc.
Issuer
AGIOS PHARMACEUTICALS, INC.
Filer
Bowden Christopher